Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Adapthealth stock
Learn how to easily invest in Adapthealth stock.
Adapthealth is a medical devices business based in the US. Adapthealth shares (AHCO) are listed on the NASDAQ and all prices are listed in US Dollars. Adapthealth employs 10,900 staff and has a trailing 12-month revenue of around $3 billion.
How to buy Adapthealth stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AHCO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Adapthealth stock price (NASDAQ: AHCO)Use our graph to track the performance of AHCO stocks over time.
Adapthealth shares at a glance
|Latest market close||$13.83|
|52-week range||$11.40 - $27.48|
|50-day moving average||$18.98|
|200-day moving average||$20.08|
|Wall St. target price||$22.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.33|
Buy Adapthealth stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Adapthealth stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adapthealth price performance over time
Historical closes compared with the close of $13.83 from 2023-03-24
|1 week (2023-03-20)||2.44%|
|1 month (2023-02-27)||-37.08%|
|3 months (2022-12-27)||-27.36%|
|6 months (2022-09-27)||-27.21%|
|1 year (2022-03-25)||-13.56%|
|2 years (2021-03-26)||-60.77%|
|3 years (2020-03-27)||15.02|
|5 years (2018-03-23)||N/A|
Is Adapthealth stock undervalued or overvalued?
Valuing Adapthealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adapthealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Adapthealth's P/E ratio
Adapthealth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Adapthealth shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Adapthealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $567.3 million.
The EBITDA is a measure of a Adapthealth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3 billion|
|Operating margin TTM||7.28%|
|Gross profit TTM||$490.8 million|
|Return on assets TTM||2.58%|
|Return on equity TTM||3.46%|
|Market capitalisation||$2 billion|
TTM: trailing 12 months
Adapthealth share dividends
We're not expecting Adapthealth to pay a dividend over the next 12 months.
Adapthealth share price volatility
Over the last 12 months, Adapthealth's shares have ranged in value from as little as $11.4 up to $27.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adapthealth's is 0.8677. This would suggest that Adapthealth's shares are less volatile than average (for this exchange).
AdaptHealth Corp. , together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania. .
Adapthealth in the news
Investors in AdaptHealth (NASDAQ:AHCO) have unfortunately lost 16% over the last year
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of AdaptHealth Corp. and Encourages Long-Term AHCO Stockholders to Contact the Firm
AdaptHealth Corp. (NASDAQ:AHCO) Q4 2022 Earnings Call Transcript
Frequently asked questionsWhat percentage of Adapthealth is owned by insiders or institutions?
Currently 23.423% of Adapthealth shares are held by insiders and 84.557% by institutions. How many people work for Adapthealth?
Latest data suggests 10,900 work at Adapthealth. When does the fiscal year end for Adapthealth?
Adapthealth's fiscal year ends in December. Where is Adapthealth based?
Adapthealth's address is: 220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 What is Adapthealth's ISIN number?
Adapthealth's international securities identification number is: US00653Q1022 What is Adapthealth's CUSIP number?
Adapthealth's Committee on Uniform Securities Identification Procedures number is: 23291E208
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert